Nuwellis (NUWE) Short term Debt (2015 - 2016)
Nuwellis (NUWE) posted Short term Debt of $3.9 million for Q2 2016, up 1.84% on a QoQ basis from $3.9 million in Q1 2016, and up 107.81% year-over-year from $1.9 million in Q3 2015.
Nuwellis (NUWE) Short term Debt (2015 - 2016) Analysis & Trends
Nuwellis' Short term Debt history runs 2 years deep, the most recent figure standing at $3.9 million for Q2 2016.
- Quarterly Short term Debt rose 107.81% year-over-year to $3.9 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $3.9 million (up 107.81% YoY) and the FY2015 annual result came in at $3.8 million, changed N/A from the prior year.
- Short term Debt was $3.9 million for Q2 2016 at Nuwellis, up from $3.9 million in the prior quarter.
- Across five years, Short term Debt topped out at $3.9 million in Q2 2016 and bottomed at $705000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 3.94 Mn |
| Mar 31, 2016 | 3.87 Mn |
| Dec 31, 2015 | 3.80 Mn |
| Sep 30, 2015 | 2.87 Mn |
| Jun 30, 2015 | 1.90 Mn |
| Mar 31, 2015 | 705,000.00 |